モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/04 | 2,527 | 2,530 | 2,412 | 2,420 | -80 | -3.2% | 435,200 |
2021/02/03 | 2,640 | 2,640 | 2,452 | 2,500 | -177 | -6.6% | 744,200 |
2021/02/02 | 2,651 | 2,697 | 2,622 | 2,677 | +74 | +2.8% | 309,100 |
2021/02/01 | 2,500 | 2,616 | 2,470 | 2,603 | +96 | +3.8% | 345,300 |
2021/01/29 | 2,658 | 2,691 | 2,456 | 2,507 | -182 | -6.8% | 553,400 |
2021/01/28 | 2,586 | 2,740 | 2,570 | 2,689 | +33 | +1.2% | 443,200 |
2021/01/27 | 2,725 | 2,754 | 2,625 | 2,656 | -69 | -2.5% | 329,500 |
2021/01/26 | 2,847 | 2,878 | 2,715 | 2,725 | -222 | -7.5% | 604,900 |
2021/01/25 | 3,020 | 3,025 | 2,899 | 2,947 | -19 | -0.6% | 579,900 |
2021/01/22 | 2,850 | 2,982 | 2,801 | 2,966 | +241 | +8.8% | 1,464,600 |
2021/01/21 | 2,640 | 2,746 | 2,620 | 2,725 | +131 | +5.1% | 597,100 |
2021/01/20 | 2,500 | 2,654 | 2,500 | 2,594 | +148 | +6.1% | 514,000 |
2021/01/19 | 2,430 | 2,468 | 2,409 | 2,446 | +81 | +3.4% | 233,100 |
2021/01/18 | 2,305 | 2,382 | 2,305 | 2,365 | +10 | +0.4% | 135,700 |
2021/01/15 | 2,405 | 2,413 | 2,334 | 2,355 | -58 | -2.4% | 204,300 |
2021/01/14 | 2,425 | 2,480 | 2,400 | 2,413 | +27 | +1.1% | 177,800 |
2021/01/13 | 2,483 | 2,520 | 2,373 | 2,386 | -92 | -3.7% | 367,300 |
2021/01/12 | 2,548 | 2,563 | 2,465 | 2,478 | -111 | -4.3% | 347,500 |
2021/01/08 | 2,488 | 2,635 | 2,484 | 2,589 | +130 | +5.3% | 717,600 |
2021/01/07 | 2,364 | 2,485 | 2,358 | 2,459 | +90 | +3.8% | 490,500 |
2021/01/06 | 2,312 | 2,405 | 2,308 | 2,369 | +124 | +5.5% | 452,800 |
2021/01/05 | 2,354 | 2,373 | 2,202 | 2,245 | -155 | -6.5% | 436,700 |
2021/01/04 | 2,220 | 2,473 | 2,220 | 2,400 | +188 | +8.5% | 789,200 |
2020/12/30 | 2,074 | 2,215 | 2,074 | 2,212 | +88 | +4.1% | 314,100 |
2020/12/29 | 1,981 | 2,136 | 1,979 | 2,124 | +149 | +7.5% | 412,600 |
2020/12/28 | 2,016 | 2,082 | 1,975 | 1,975 | -42 | -2.1% | 317,200 |
2020/12/25 | 1,980 | 2,077 | 1,970 | 2,017 | +44 | +2.2% | 322,000 |
2020/12/24 | 1,892 | 2,035 | 1,892 | 1,973 | +75 | +4% | 548,700 |
2020/12/23 | 1,870 | 1,907 | 1,801 | 1,898 | +21 | +1.1% | 422,200 |
2020/12/22 | 1,890 | 1,938 | 1,816 | 1,877 | -14 | -0.7% | 590,700 |
2020/12/21 | 1,895 | 1,943 | 1,741 | 1,891 | -35 | -1.8% | 862,400 |
2020/12/18 | 1,815 | 2,013 | 1,814 | 1,926 | +132 | +7.4% | 1,043,600 |
2020/12/17 | 1,800 | 1,844 | 1,701 | 1,794 | -65 | -3.5% | 2,211,700 |
2020/12/16 | 1,859 | 1,859 | 1,859 | 1,859 | -500 | -21.2% | 82,400 |
2020/12/15 | 2,401 | 2,435 | 2,329 | 2,359 | -56 | -2.3% | 167,700 |
2020/12/14 | 2,348 | 2,436 | 2,319 | 2,415 | +103 | +4.5% | 258,000 |
2020/12/11 | 2,234 | 2,399 | 2,223 | 2,312 | +98 | +4.4% | 370,000 |
2020/12/10 | 2,342 | 2,350 | 2,204 | 2,214 | -145 | -6.1% | 408,000 |
2020/12/09 | 2,391 | 2,442 | 2,351 | 2,359 | -28 | -1.2% | 242,300 |
2020/12/08 | 2,350 | 2,428 | 2,331 | 2,387 | +32 | +1.4% | 252,500 |
2020/12/07 | 2,502 | 2,502 | 2,351 | 2,355 | -97 | -4% | 331,100 |
2020/12/04 | 2,440 | 2,502 | 2,430 | 2,452 | +9 | +0.4% | 257,300 |
2020/12/03 | 2,529 | 2,559 | 2,442 | 2,443 | -86 | -3.4% | 321,000 |
2020/12/02 | 2,477 | 2,575 | 2,477 | 2,529 | +43 | +1.7% | 418,500 |
2020/12/01 | 2,423 | 2,501 | 2,423 | 2,486 | -15 | -0.6% | 297,500 |
2020/11/30 | 2,469 | 2,513 | 2,430 | 2,501 | +68 | +2.8% | 531,300 |
2020/11/27 | 2,418 | 2,433 | 2,362 | 2,433 | +15 | +0.6% | 245,800 |
2020/11/26 | 2,362 | 2,424 | 2,352 | 2,418 | +51 | +2.2% | 252,800 |
2020/11/25 | 2,434 | 2,482 | 2,350 | 2,367 | -69 | -2.8% | 376,300 |
2020/11/24 | 2,430 | 2,475 | 2,420 | 2,436 | +7 | +0.3% | 220,100 |
1051~
1100
件表示中 / 1176件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 7,600円 | - | - | 0.00% | - | 1.62倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
NPT | - | - | - | - | - | - |
|
- |
クリングル | 84,100円 | +240.0% | - | 0.00% | - | 3.63倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
カイノス | 123,600円 | +3.7% | +2.7% | 2.59% | 8.68倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
DELTA-P | 57,200円 | - | - | 0.00% | - | 20.24倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム